Apr 15, 2020, 15:49 by

Located on the Tufts University Medford, MA campus, this new donor center will enable delivery of fresh blood, leukopaks and buffy coats for COVID-19, cell and gene therapy research within hours of collection.

Apr 15, 2020, 15:49 by

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has launched a complimentary COVID-19 risk management package available to all at no cost. With the FDA, EMA, PMDA and MHRA issuing specific guidelines as a result of the coronavirus, the CluePoints package will help meet these new recommendations and address additional study risks. The platform includes a widely used online Risk Assessment and Control solution that can be leveraged for performing risk planning and mitigation activities addressing inherent risks during this crisis. Register here for the COVID-19 risk management package.

Apr 15, 2020, 15:49 by

Independent Site Management Organisation Panthera is working with sponsors who need to press ahead with trials which can be done safely.

Apr 15, 2020, 15:49 by

Sharp Clinical, part of UDG Healthcare and a leading provider of global clinical supply services, has confirmed that it is involved in supporting six clinical trials related to COVID-19.

Apr 15, 2020, 15:49 by

Apr 15, 2020, 15:49 by

TrialAssure® announced today that it will offer academic institutions free access to TrialAssure REGISTRY—the premiere clinical trial disclosure reporting application.

Apr 15, 2020, 15:49 by

Apr 15, 2020, 15:49 by

Clinical Ink, a global clinical trial technology company, has made a commitment to donate several hundred mobile phones and tablets to Thrive Behavioral Health for individual and family mental tele-health services, which are largely replacing in-person sessions during the COVID-19 crisis.

Apr 15, 2020, 15:49 by

A newly validated app called Rafi-Tone, developed by clinicians in the UK, makes using an inhaler with a spacer easier and more fun for young children with wheeze or asthma symptoms.

Apr 15, 2020, 15:49 by

BSC is collecting blood samples from sick and recovered COVID-19 patients to assist in developing COVID-19 therapies, vaccines and diagnostic biomarkers.

Apr 15, 2020, 08:06 by User Not Found

Clinical Research News | A non-profit foundation is spearheading legislation that give thousands of underserved and hopeful cancer patients access to clinical trials and potential life-saving drugs.

Apr 14, 2020, 12:10 by User Not Found

Clinical Research NewsThe National Institutes of Health announced a new study last week to determine how many adults in the United States without a confirmed history of infection with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), have antibodies to the virus indicating a prior infection.

Apr 10, 2020, 12:31 by User Not Found

Clinical Research News | The SARS-CoV-2 virus is serving as a rallying cry across the clinical research landscape, inspiring creative new solutions, partnerships, and ideas to address the outbreak, treat and prevent the disease it causes, and address the life adjustments of our new normal.

Apr 9, 2020, 09:41 by User Not Found

Clinical Research News | The machine learning capabilities of four companies were put to the test in a first-of-its-kind hackathon organized by Pfizer late last year where the singular goal was to see whether artificial intelligence (AI) could predict and identify data discrepancies from datasets of 30 completed clinical trials.

Apr 7, 2020, 09:01 by User Not Found

Clinical Research News | A survey conducted by Clinical Research News shows a highly fragmented market when it comes to clinical trial management systems.

Apr 3, 2020, 16:25 by

Company’s expertise, infrastructure and flexibility enable remote ECG assessment for fast-tracked COVID-19 vaccines /therapies and other critical pharmaceuticals

Apr 3, 2020, 16:25 by

CD Bioparticles introduces carbon-based nanocages production services to global researchers.

Apr 3, 2020, 16:25 by

PHARMASEAL International, provider of clinical trials management systems has today announced that it will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus clinical trials. The free offer to utilize Engility CTMS is open to biopharmaceutical organizations and academic institutions.

Apr 3, 2020, 16:25 by

High-quality clinician-administered data collected during patient home visits advances respiratory trials throughout COVID-19 pandemic

Apr 3, 2020, 16:24 by

Serimmune, a leader in understanding the functional antibody repertoire’s role in human disease, today announced that the company has received a research milestone payment from Merck (known as MSD outside the United States and Canada) under its ongoing discovery and development collaboration agreement.